Citigroup’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,442
| Closed | -$2K | – | 6073 |
|
|
2022
Q1 | $2K | Sell |
1,442
-3,527
| -71% | -$4.89K | ﹤0.01% | 5298 |
|
|
2021
Q4 | $12K | Buy |
4,969
+436
| +10% | +$1.05K | ﹤0.01% | 4759 |
|
|
2021
Q3 | $25K | Buy |
4,533
+972
| +27% | +$5.36K | ﹤0.01% | 4395 |
|
|
2021
Q2 | $26K | Buy |
3,561
+1,668
| +88% | +$12.2K | ﹤0.01% | 4490 |
|
|
2021
Q1 | $15K | Sell |
1,893
-1,432
| -43% | -$11.3K | ﹤0.01% | 4756 |
|
|
2020
Q4 | $30K | Buy |
3,325
+1,897
| +133% | +$17.1K | ﹤0.01% | 4410 |
|
|
2020
Q3 | $16K | Sell |
1,428
-59,093
| -98% | -$662K | ﹤0.01% | 4083 |
|
|
2020
Q2 | $449K | Buy |
60,521
+56,186
| +1,296% | +$417K | ﹤0.01% | 2632 |
|
|
2020
Q1 | $27K | Buy |
4,335
+1,886
| +77% | +$11.7K | ﹤0.01% | 4211 |
|
|
2019
Q4 | $12K | Buy |
2,449
+1,599
| +188% | +$7.84K | ﹤0.01% | 4676 |
|
|
2019
Q3 | $6K | Sell |
850
-564
| -40% | -$3.98K | ﹤0.01% | 4754 |
|
|
2019
Q2 | $16K | Sell |
1,414
-968
| -41% | -$11K | ﹤0.01% | 4651 |
|
|
2019
Q1 | $35K | Buy |
+2,382
| New | +$35K | ﹤0.01% | 4255 |
|